Preferred Label : azacitidine;
MeSH definition : A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation.
It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine
has been used as an antineoplastic agent.;
MeSH synonym : 5 azacytidine; 5-azacytidine; Azacytidine;
CISMeF synonym : 2-(.beta.-d-ribofuranosyl)-4-amino-1,3,5-triazin-2-one; pharmion brand of azacitidine;
MeSH hyponym : NSC-102816; vidaza; NSC 102816; NSC102816;
MeSH CAS label : 1,3,5-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-;
MeSH Related Number : 320-67-2 (Azacitidine);
Registry Number MeSH : 320-67-2;
Wikipedia link : https://en.wikipedia.org/wiki/Azacitidine;
Codes EINECS : 206-280-2;
Is substance : O;
UNII : M801H13NRU;
InChIKey : NMUSYJAQQFHJEW-KVTDHHQDSA-N;
Origin ID : D001374;
UMLS CUI : C0004475;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- CP 4200 [MeSH Supplementary Concept]
- cc-486 [MeSH Supplementary Concept]
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation.
It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine
has been used as an antineoplastic agent.
https://www.ema.europa.eu/en/medicines/human/EPAR/azacitidine-kabi
2024
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
drugs, generic
drug approval
azacitidine
azacitidine
---
https://www.ema.europa.eu/en/medicines/human/EPAR/onureg
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
azacitidine
azacitidine
azacitidine
antimetabolites, antineoplastic
antimetabolites, antineoplastic
leukemia, myeloid, acute
administration, oral
Acute Myeloid Leukemia in Remission
Maintenance therapy (procedure)
adult
aged
drug interactions
pregnancy
breast feeding
Female of Childbearing Potential
DNA Methyltransferase Inhibitor
drug evaluation, preclinical
---
https://ansm.sante.fr/tableau-atu-rtu/onureg-200-mg-et-300-mg-comprime-pellicule
2021
false
false
false
France
French
administration, oral
azacitidine
azacitidine
guidelines for drug use
adult
leukemia, myeloid, acute
summary of product characteristics
package leaflet
drug monitoring
Product containing precisely azacitidine 200 milligram/1 each conventional release
oral tablet (clinical drug)
Product containing precisely azacitidine 300 milligram/1 each conventional release
oral tablet (clinical drug)
continuity of patient care
antimetabolites, antineoplastic
antimetabolites, antineoplastic
azacitidine
---
https://www.has-sante.fr/jcms/p_3305324/fr/onureg-200-300-mg-azacitidine
2021
false
false
false
France
evaluation of the transparency committee
azacitidine
registries
---
https://www.has-sante.fr/jcms/p_3194121/fr/azacitidine-zentiva
2020
false
false
false
France
drugs, generic
azacitidine
evaluation of the transparency committee
azacitidine
---
https://www.ema.europa.eu/en/medicines/human/EPAR/azacitidine-mylan
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drugs, generic
drug approval
europe
azacitidine
azacitidine
azacitidine
antimetabolites, antineoplastic
antimetabolites, antineoplastic
adult
aged
myelodysplastic syndromes
leukemia, myelomonocytic, chronic
leukemia, myeloid, acute
injections, subcutaneous
pregnancy
breast feeding
drug evaluation, preclinical
---
https://www.ema.europa.eu/en/medicines/human/EPAR/azacitidine-betapharm
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
azacitidine
azacitidine
azacitidine
antimetabolites, antineoplastic
antimetabolites, antineoplastic
drugs, generic
adult
myelodysplastic syndromes
leukemia, myelomonocytic, chronic
DNA Methyltransferase
injections, subcutaneous
aged
fertility
pregnancy
breast feeding
drug evaluation, preclinical
---
https://www.has-sante.fr/jcms/p_3193730/fr/azacitidine-sandoz
2020
false
false
false
France
drugs, generic
azacitidine
evaluation of the transparency committee
azacitidine
---
https://www.has-sante.fr/jcms/p_3181458/fr/azacitidine-mylan
2020
false
false
false
France
azacitidine
drugs, generic
evaluation of the transparency committee
azacitidine
---
https://www.ema.europa.eu/en/medicines/human/EPAR/azacitidine-accord
2020
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
azacitidine
drug approval
europe
treatment outcome
drugs, generic
antimetabolites, antineoplastic
antimetabolites, antineoplastic
azacitidine
adult
myelodysplastic syndromes
leukemia, myelomonocytic, chronic
leukemia, myeloid, acute
injections, subcutaneous
pregnancy
breast feeding
drug evaluation, preclinical
azacitidine
---
https://www.has-sante.fr/jcms/p_3161430/fr/azacitidine-accord
2020
false
false
false
France
drugs, generic
azacitidine
evaluation of the transparency committee
azacitidine
---
https://www.has-sante.fr/jcms/p_3193440/fr/azacitidine-betapharm
2020
false
false
false
France
azacitidine
drugs, generic
evaluation of the transparency committee
azacitidine
---
https://www.ema.europa.eu/en/medicines/human/EPAR/azacitidine-celgene
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
azacitidine
azacitidine
azacitidine
antimetabolites, antineoplastic
antimetabolites, antineoplastic
adult
myelodysplastic syndromes
leukemia, myelomonocytic, chronic
leukemia, myeloid, acute
injections, subcutaneous
aged
fertility
pregnancy
breast feeding
DNA Methyltransferase Inhibitor
drug evaluation, preclinical
---
http://conseil-scientifique.public.lu/fr/publications/oncologie/azacitidine-mise-a-jour-2018.html
2018
false
false
true
Luxembourg
French
guidelines for drug use
injections, subcutaneous
azacitidine
azacitidine
adult
antimetabolites, antineoplastic
leukemia, myeloid, acute
myelodysplastic syndromes
leukemia, myelomonocytic, chronic
treatment outcome
---
https://www.has-sante.fr/portail/jcms/c_2777959/fr/vidaza
https://www.has-sante.fr/portail/jcms/c_2777959/fr/vidaza-azacitidine-antimetabolite
2017
false
France
French
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
adult
Ineligibility
hematopoietic stem cell transplantation
azacitidine
antimetabolites, antineoplastic
leukemia, myeloid, acute
azacitidine
evaluation of the transparency committee
guidelines for drug use
---
https://pgtmsite.files.wordpress.com/2024/01/5-azacitidine_ad_version-finale_site-public_20151112.pdf
2015
Canada
drug information
Gleason Grade Group 5
Thought Score 5
Agreement Score 5
Phase V Trial
Death Related to Adverse Event
Use
Severity of Symptom Score 5
myelodysplasia
Illness Intrusiveness Rating 5
Loss of Chromosome 5
Intensity and Distress 5
myelodysplastic syndromes
NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology
Analyzed
Analysis
Adult Myelodysplastic Syndrome
Clinical Status Ordinal Scale Outcome 5
Fear Score 5
Childhood Myelodysplastic Syndrome
Identifier
Description
azacitidine
Azacitidine
ECOG Performance Status 5
Current Reformed Smoker, Years Unknown
Neck Pain Score 5
Upset Score 5
---
https://pgtmsite.files.wordpress.com/2024/01/5-azacitidine_ad_protocole_versionfinale_site-public_20150720.pdf
2015
Canada
drug information
ECOG Performance Status 5
Agreement Score 5
Fear Score 5
Phase V Trial
Current Reformed Smoker, Years Unknown
Death Related to Adverse Event
Gleason Grade Group 5
Clinical Status Ordinal Scale Outcome 5
Upset Score 5
azacitidine
Thought Score 5
Severity of Symptom Score 5
Azacitidine
Loss of Chromosome 5
Neck Pain Score 5
Illness Intrusiveness Rating 5
Intensity and Distress 5
---
https://pgtmsite.files.wordpress.com/2024/01/azacitidine_es_20120430.pdf
2012
Canada
drug information
myelodysplastic syndromes
leukaemia
Adult Acute Myeloid Leukemia
Treat
Childhood Myelodysplastic Syndrome
During Treatment
Myelodysplastic Syndrome Acute Myeloid Leukemia
Childhood Acute Myeloid Leukemia
Treatment Study
Therapy Object
NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology
Biomaterial Treatment
Adult Myelodysplastic Syndrome
AML Lab Table
Treatment Epoch
NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology
Azacitidine
leukemia, myeloid, acute
Acute Myeloid Leukemia without Maturation
On Treatment
GDC Treatment Frequency Terminology
Acute Myeloid Leukemia with KMT2A Rearrangement
azacitidine
Treatment
No Treatment for Diabetes
Acute Myeloid Leukemia Pathway
myelodysplasia
---
https://www.ema.europa.eu/medicines/human/EPAR/Vidaza
2012
United Kingdom
English
French
syndication feed
orphan drug production
antimetabolites, antineoplastic
enzyme inhibitors
azacitidine
adult
drug approval
myelodysplastic syndromes
leukemia, myelomonocytic, chronic
treatment outcome
antimetabolites, antineoplastic
enzyme inhibitors
azacitidine
injections, subcutaneous
aged
drug interactions
pregnancy
breast feeding
drug screening assays, antitumor
drug compounding
leukemia, myeloid, acute
azacitidine
summary of product characteristics
package leaflet
drug evaluation
---
http://www.gfmgroup.org/fichiers/recommandations/recommandation_20100215182052.pdf
2010
false
false
France
French
diagnostic uses of chemicals
myelodysplastic syndromes
azacitidine
antimetabolites, antineoplastic
azacitidine
antimetabolites, antineoplastic
guidelines for drug use
---
VIDAZA - Summary Basis of Decision
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00304
2010
false
Canada
French
English
drug information
azacitidine
azacitidine
antimetabolites, antineoplastic
antimetabolites, antineoplastic
azacitidine
treatment outcome
injections, subcutaneous
drug approval
adult
myelodysplastic syndromes
leukemia, myeloid, acute
canada
drug evaluation, preclinical
---
http://www.has-sante.fr/portail/jcms/c_825516/vidaza-azacitidine-antimetabolite
http://www.has-sante.fr/portail/jcms/c_825515/synthese-d-avis-vidaza-ct-6362
http://www.has-sante.fr/portail/jcms/c_799898/vidaza-ct-6362
2009
France
French
myelodysplastic syndromes
azacitidine
antimetabolites, antineoplastic
leukemia, myelomonocytic, chronic
leukemia, myeloid, acute
azacitidine
evaluation of the transparency committee
guidelines for drug use
---
http://www.legifrance.gouv.fr/jo_pdf.do?cidTexte=JORFTEXT000020125124
2009
France
French
azacitidine
legislation, drug
legislation
drug information
---